Review article · 2026 · Open access
Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development
Small, 22(64), e76030 · Published 30 September 2026 · DOI 10.1002/smll.76030
In brief
“Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development” is a 2026 review article by Lei Xiu and 8 co-authors, published in Small. OpenAlex counts 0 citations as of 21 November 2026. It is open access: the full text is free to read at Small.
- Citations
- 0
- References
- 248
- Authors
- 9
Abstract
Microphysiological systems (MPS) have emerged as transformative in vitro platforms to address the long-standing bottlenecks of conventional preclinical models, including poor physiological relevance inherent to 2D cultures, as well as species incompatibility and ethical constraints associated with animal models, thereby improving clinical predictability and redefining modern pharmaceutical development. This review highlights the innovative convergence of bioprinting, organoids, organ-on-a-chip (OoC), and artificial intelligence (AI) as a next-generation MPS framework, enabling precision reconstruction of human tissue microenvironments with unprecedented fidelity. Bioprinting delivers spatially defined 3D architectures; organoids recapitulate organ-specific heterogeneity; OoC integrates dynamic physiological cues; and AI enables intelligent fabrication optimization, real-time monitoring, and predictive drug-response modeling. Their synergistic integration overcomes the inherent limitations of single-technology systems. We emphasize state-of-the-art MPS applications in disease-drug screening, and toxicological assessment across tissues and multiorgan crosstalk models, underscoring their paradigm-shifting potential. Remaining challenges, such as long-term functional maturation, vascularization complexity, and standardized validation, and future directions, including multi-cue integration, modular scalability, and AI-driven in vitro-in vivo correlation, are concisely outlined. This interdisciplinary synthesis establishes MPS as a cornerstone technology to accelerate pharmaceutical innovation, reduce reliance on animal models, and advance precision medicine toward clinical translation, thereby filling a critical gap in current biomedical research.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Xiu, L., Zhang, J., Bong, W., Jeong, S., Yue, T., Hann, S.-Y., Wang, Y., Cui, H., & Zhang, L. G. (2026). Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development. Small, 22(64), e76030. https://doi.org/10.1002/smll.76030
MLA 9
Xiu, Lei, et al. “Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development.” Small, vol. 22, no. 64, 2026, p. e76030. https://doi.org/10.1002/smll.76030.
Chicago
Xiu, Lei, Juan Zhang, Wooseung Bong, Seojune Jeong, Tao Yue, Sung-Yun Hann, Yue Wang, Haitao Cui, and Lijie Grace Zhang. 2026. “Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development.” Small 22 (64): e76030. https://doi.org/10.1002/smll.76030.
Harvard
Xiu, L. et al. (2026) ‘Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development’, Small, 22(64), p. e76030. doi:10.1002/smll.76030.
IEEE
L. Xiu et al., “Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development,” Small, vol. 22, no. 64, p. e76030, 2026, doi: 10.1002/smll.76030.
BibTeX
@article{xiu2026microphysiological,
title = {{Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development}},
author = {Xiu, Lei and Zhang, Juan and Bong, Wooseung and Jeong, Seojune and Yue, Tao and Hann, Sung-Yun and Wang, Yue and Cui, Haitao and Zhang, Lijie Grace},
journal = {Small},
year = {2026},
volume = {22},
number = {64},
pages = {e76030},
doi = {10.1002/smll.76030},
url = {https://doi.org/10.1002/smll.76030}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- microphysiological systems
- bioprinting
- organoids
- organ-on-a-chip
- artificial intelligence
- in vitro disease model
- drug screening
- toxicity prediction
Work with this paper
Most-cited papers in Engineering
- A Closed‐form Equation for Predicting the Hydraulic Conductivity of Unsaturated SoilsMartinus Th. van Genuchten · Soil Science Society of America Journal · 1980 · 28,197 citations
- An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experimentsW. C. Oliver, George M. Pharr · Journal of materials research/Pratt's guide to venture capital sources · 1992 · 27,379 citations
- Digital communicationsOwen Bishop · Routledge eBooks · 2007 · 24,890 citations
- The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysisNorden Eh Huang, Zhengwei Shen, Steven R. Long and 6 more · Proceedings of the Royal Society A Mathematical Physical and Engineering Sciences · 1998 · 24,008 citations
- Numerical Heat Transfer and Fluid FlowSuhas V. Patankar · CRC Press eBooks · 2018 · 23,491 citations
Questions about this paper
How do I cite this paper in APA style?
Xiu, L., Zhang, J., Bong, W., Jeong, S., Yue, T., Hann, S.-Y., Wang, Y., Cui, H., & Zhang, L. G. (2026). Microphysiological Systems Integrating Bioprinting, Organoids, Organ‐on‐a‐Chip, and AI: Next Generation Platforms for Pharmaceutical Development. Small, 22(64), e76030. https://doi.org/10.1002/smll.76030
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Small: sign in and open the PDF from this page.
Who wrote this paper?
Lei Xiu, Juan Zhang, Wooseung Bong, Seojune Jeong, Tao Yue, Sung-Yun Hann, Yue Wang, Haitao Cui, Lijie Grace Zhang.
What is the DOI of this paper?
10.1002/smll.76030, permanently at https://doi.org/10.1002/smll.76030. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.